Clinical trial
Biological Therapy in Treating Women With Breast Cancer That Has Spread to the…
NCT00301106 · Max Sung, Other · Terminated
Key facts
| NCT number | NCT00301106 |
|---|---|
| Title | Biological Therapy in Treating Women With Breast Cancer That Has Spread to the Liver |
| Official title | Phase I Trial of Adenoviral Vector Delivery of the Human Interleukin-12 cDNA by Intratumoral Injection in Patients With Metastatic Breast Cancer to the Liver |
| Lead sponsor | Max Sung, Other |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer, Metastatic Cancer |
| Intervention type | Biological |
| Interventions | adenovirus-mediated human interleukin-12 |
| Enrollment | 2 |
| Start date | Oct 1, 2005 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Mar 10, 2006 |
| Last update posted | Feb 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: